Paris saponin VII (Standard) is the analytical standard for Paris saponin VII, intended for research and analytical applications. Paris saponin VII (Chonglou Saponin VII), a steroidal saponin from Trillium tschonoskii, induces apoptosis in K562/ADR cells via Akt/MAPK and P-gp inhibition. It attenuates mitochondrial membrane potential, increases apoptosis-related proteins (e.g., Bax, cytochrome c), and decreases Bcl-2, caspase-9, caspase-3, PARP-1, and p-Akt levels. It also induces robust autophagy in K562/ADR cells, providing a biochemical basis for leukemia treatment.
- Home
- Mitochondrial Diseases & Models
- By System Involvement
- Systemic Mitochondrial Disease
- Alpers Disease
- Barth Syndrome
- Carnitine Deficiency
- Creatine Deficiency Syndromes
- Co-Enzyme Q10 Deficience
- Friedreich’s Ataxia
- Kearns-Sayre Syndrome
- Lactic Acidosis
- Leigh Syndrome
- Mitochondrial DNA Depletion Syndrome
- MELAS Syndrome
- Multiple Mitochondrial Dysfunction Syndrome
- Short-Chain Acyl-CoA Dehydrogenase Deficiency
- Thymidine Kinase 2 Deficiency
- Mitochondrial Neurogastrointestinal Encephalopathy
- Organ-specific Mitochondrial Diseases
- Systemic Mitochondrial Disease
- By Etiology
- By System Involvement
- Solutions
- Products
- Mitochondrial Isolation Reagents & Kits
- Mitochondrial Staining Reagents & Kits
- Mitochondrial Disease Diagnostic Reagents & Kits
- Biochemical Inhibitors & Activators
- Mitochondrial Specific Antibodies
- Mitochondrial Recombinant Proteins
- Mitochondria Related Peptides
- Natural Products Targeting Mitochondria
- Resource
- Company